Status:
UNKNOWN
BEnefits of Stroke Treatment Delivered Using a Mobile Stroke Unit
Lead Sponsor:
Memorial Hermann Health System
Collaborating Sponsors:
The University of Texas Health Science Center, Houston
Baylor College of Medicine
Conditions:
Acute Ischemic Stroke
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The primary goal of this project is to carry out a trial comparing pre-hospital diagnosis and treatment of patients with stroke symptoms using a Mobile Stroke Unit (MSU) with subsequent transfer to a ...
Detailed Description
There are many ways that use of a MSU might prove valuable in stroke patients, but we will focus on acute ischemic stroke (AIS) and treatment with IV tissue plasminogen activator (tPA) within 4.5 hour...
Eligibility Criteria
Inclusion
- Last seen normal within 4hr 30 min of symptom onset
- History and physical/neurological examination consistent with acute stroke
- No tPA exclusions per guidelines, prior to CT scan or baseline labs
- Informed consent obtained from patient (if competent) or legal representative.
Exclusion
- None
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2023
Estimated Enrollment :
1038 Patients enrolled
Trial Details
Trial ID
NCT02190500
Start Date
August 1 2014
End Date
August 1 2023
Last Update
March 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Health Science Center, Houston
Houston, Texas, United States, 77030